arrow
I

Irene Hallyburton

university of dundee
H指数:21
被引数:2,448

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static-Cidal Screening of Analogues
2023-06-211
OAAI
Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2
2022-10-137
OAAI
An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel Antimalarials
2021-11-0810
OA
Substituted Aminoacetamides as Novel Leads for Malaria Treatment
2019-07-036
OAAI
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
2019-03-20111
OAAI
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
2018-11-0153
OAAI
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors
2018-09-1245
OAAI
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase
2016-11-1644
OAAI
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles

开源药物发现: 源自Tres Cantos芳基吡咯的高效抗疟化合物

2016-09-1454
OAAI
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
2016-09-1071
OAAI
Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials
2016-06-1713
OAAI
Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode
2015-09-2323
OAAI